5-(3-chlorophenyl)-3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole

ID: ALA502716

PubChem CID: 12002522

Max Phase: Preclinical

Molecular Formula: C13H11ClN6

Molecular Weight: 286.73

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1cccc(C2Cc3[nH]nc(-c4nnn[nH]4)c3C2)c1

Standard InChI:  InChI=1S/C13H11ClN6/c14-9-3-1-2-7(4-9)8-5-10-11(6-8)15-16-12(10)13-17-19-20-18-13/h1-4,8H,5-6H2,(H,15,16)(H,17,18,19,20)

Standard InChI Key:  FDSMQUMEVKUVPA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
   14.8030  -13.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2730  -13.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3027  -12.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0815  -12.8643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0624  -13.6863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8382  -13.9585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3369  -13.3048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8693  -12.6286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0748  -14.7489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5743  -15.4036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0436  -16.0822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8340  -15.8456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8532  -15.0207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9782  -13.2302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5868  -12.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7628  -12.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3337  -13.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7345  -13.9177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5573  -13.9328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3087  -14.6243    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  9 10  1  0
  1  2  1  0
  2  5  1  0
  4  3  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  3  1  1  0
  1 14  1  0
  5  6  1  0
 14 15  2  0
  6  7  2  0
 15 16  1  0
  7  8  1  0
 16 17  2  0
  8  4  1  0
 17 18  1  0
  4  5  2  0
 18 19  2  0
 19 14  1  0
  6  9  1  0
 18 20  1  0
M  END

Associated Targets(Human)

HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hcar2 Hydroxycarboxylic acid receptor 2 (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 286.73Molecular Weight (Monoisotopic): 286.0734AlogP: 2.13#Rotatable Bonds: 2
Polar Surface Area: 83.14Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.38CX Basic pKa: 1.27CX LogP: 2.74CX LogD: 1.13
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.76Np Likeness Score: -1.53

References

1. Imbriglio JE, Chang S, Liang R, Raghavan S, Schmidt D, Smenton A, Tria S, Schrader TO, Jung JK, Esser C, Taggart AK, Cheng K, Carballo-Jane E, Gerard Waters M, Tata JR, Colletti SL..  (2009)  GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.,  19  (8): [PMID:19307116] [10.1016/j.bmcl.2009.03.014]

Source